LCM
SRNE

Landscape Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Landscape Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-49,074
Closed -$353K – 823
2018
Q2 		$353K Buy
+49,074
New +$334K 0.03% 356
2016
Q1 		– Sell
-54,634
Closed -$476K – 893
2015
Q4 		$476K Buy
+54,634
New +$461K 0.06% 508

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Landscape Capital Management's SRNE Position: Q3 2018 in Review

Landscape Capital Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2018, closing a stake of 49,074 shares — an estimated $353K sold.

Landscape Capital Management first reported a position in SRNE in Q4 2015 and held it in 2 quarters. The position peaked at $476K in Q4 2015. 97 funds tracked by Wall St. Rank hold SRNE as of Q3 2018.

  • Landscape Capital Management reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Landscape Capital Management sold 49,074 Sorrento Therapeutics, Inc. shares in Q3 2018, an estimated $353K.
  • Landscape Capital Management first reported a position in Sorrento Therapeutics, Inc. in Q4 2015 and held it in 2 quarters.
  • Landscape Capital Management's Sorrento Therapeutics, Inc. position peaked at $476K in Q4 2015.
  • 97 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2018.

Based on Landscape Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.